Tiletamine Hcl And Zolazepam Hcl

34 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

4410.0%

Death Rate

Active Ingredients

Tiletamine Hcl And Zolazepam Hcl

Administration Routes

IntramuscularUnknownIntravenousParenteralSubcutaneous

Species Affected

Dog 18

Cat 15

Unknown 1

Most Affected Breeds

Cat (unknown) 9

Dog (unknown) 9

Domestic Shorthair 6

Crossbred Canine/dog 1

Unknown 1

Basenji 1

Shepherd Dog - German 1

Spaniel (unspecified) 1

Poodle - Standard 1

Bulldog 1

Most Reported Reactions

Lack of efficacy - NOS 16

Death by euthanasia 8

Hyperthermia 4

Unrelated death 4

Hypothermia 2

Vomiting 2

Sudden death 2

Death 2

Immediate pain upon injection 2

INEFFECTIVE, EUTHANASIA 1

Mydriasis 1

Neurological signs NOS 1

Outcome Breakdown

Recovered/Normal

12 (36.4%)

Euthanized

11 (33.3%)

Outcome Unknown

5 (15.2%)

Died

4 (12.1%)

Ongoing

1 (3.0%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.